Translational Development Acquisition Corp Files Proxy Statement for Shareholder Meeting Regeneron REGN and Parabilis Medicines Forge 232 Billion Deal to Tackle Undruggable Protein Targets US Jobless Claims Remain at Historically Low Levels Signaling Labor Market Resilience Morgan Stanley Adjusts Palo Alto Networks PANW Price Target Amid Evolving Demand Trends Marco Rubio Navigates CubanAmerican Opposition While Pursuing Economic Engagement with Havana SpaceX Scrubs Starship Test Flight Sets Friday for Next Attempt Amid IPO Prospectus Release Sunstone Hotel Investors Inc SHO Q1 2026 Earnings Strong EPS Surprise of 98 Outperforms Estimates Despite Stock Dip Leonardo DRS Inc DRS Q1 2026 Earnings EPS Surges Past Estimates as Defense Demand Remains Robust Brilliant Earth Group Inc BRLT Q1 2026 Earnings EPS Misses Estimates But Stock Rises on Operational Developments AMX Q1 2026 Earnings EPS Beats Estimates Amid Subscriber Growth and Cost Control NetEase NTES Q1 2026 Earnings Strong EPS Beat Driven by Gaming and Cost Discipline DCGO Q1 2026 Earnings EPS Misses Estimates as Stock Rises 514 CPI Card Group Inc PMTS Surges 798 as Stock Approaches Key Resistance Church Dwight CHD Holds Steady with Modest Gains as Defensive Appeal Endures Civeo Corporation CVEO Sees Modest Decline Amid Consolidation Milestone Pharmaceuticals MIST Slides 724 as Selling Pressure BuildsKey Support at 134 in Focus WF International WXM Holds Steady at 046 as Traders Eye Key Levels SP 500 Edges Higher as Tech Surge Offsets Energy Slide SpaceX Starship V3 Test Flight Scrubbed Rescheduled for Friday GMO Warns Classic 6040 Portfolio May Face Lost Decade of Returns One House Three Owners How Home Affordability Has Transformed the American Dream Mortgage Rates Decline Across the Board on May 27 2026 Extending Recent Downward Trend Walmarts SafeHaven Status Tested as High Gas Prices Weigh on Shares China Confirms Order for 200 Boeing Jets Calls Aviation a Key Area for Bilateral Cooperation Ascent Industries Co ACNT Q1 2025 Earnings EPS Misses Estimates Stock Declines MIRA Pharmaceuticals Edges Higher Consolidating Near Key Resistance at 104